Showing 7851-7860 of 20882 results for "".
- UofL Study Shows Nicotine in E-Cigarettes May Not Be Harmless, As Some Claimhttps://reachmd.com/news/uofl-study-shows-nicotine-in-e-cigarettes-may-not-be-harmless-as-some-claim/2456785/With the start of a new year, smokers and vapers may have resolved to quit or cut back on the habit to improve their health. They may want to use caution, however, if their strategy involves switching from cigarettes to e-cigarettes, considered by some to be a less harmful a
- Soft, Wearable Robot Helps a Person with Parkinson's to Walk Without Freezinghttps://reachmd.com/news/soft-wearable-robot-helps-a-person-with-parkinsons-to-walk-without-freezing/2456779/Freezing is one of the most common and debilitating symptoms of Parkinson's disease, a neurodegenerative disorder that affects more than 9 million people worldwide. When individuals with Parkinson's disease freeze, they suddenly lose the ability t
- A New Approach Can Address Antibiotic Resistance to Mycobacterium Abscessushttps://reachmd.com/news/a-new-approach-can-address-antibiotic-resistance-to-mycobacterium-abscessus/2456781/Overcoming efflux to make a more effective antibiotic Through their work, the scientists unraveled the mechanism of action by which eAmSPCs are more effective: they circumvent efflux. Efflux is the process that cells use to get rid of a drug — imagine pumping water out of
- Patient with Skin Cancer Receives First Dose of Novel Cancer Vaccinehttps://reachmd.com/news/patient-with-skin-cancer-receives-first-dose-of-novel-cancer-vaccine/2456741/A patient in a phase 2 trial has received the first dose of a novel cancer vaccine in combination with Keytruda (pembrolizumab) as neoadjuvant (treatment before main treatment) and adjuvant (treatment after main treatment) therapy in patients with solid tumors, according to IO Biotech,
- Removing a Protein Could Prevent Aging and Obesity from Evolving into Metabolic Diseases, Research Suggestshttps://reachmd.com/news/removing-a-protein-could-prevent-aging-and-obesity-from-evolving-into-metabolic-diseases-research-suggests/2456744/The ribotoxic stress response drives metabolic maladaptation in obesity and aging. ROS are a physiologically relevant source of translational impairment and activation of the stress kinas
- Study Finds Paxlovid Treatment Does Not Reduce Risk of Long COVIDhttps://reachmd.com/news/study-finds-paxlovid-treatment-does-not-reduce-risk-of-long-covid/2456766/A team of researchers from UC San Francisco has found that Paxlovid did not reduce the risk of developing long COVID for vaccinated, non-hospitalized individuals during their first COVID-19 infection. They also found that a higher proportion of individuals than previously reported exper
- Beta Blocker Used to Treat Heart Problems and Other Medical Concerns Could Be New Treatment for Sickle Cell Cardiomyopathyhttps://reachmd.com/news/beta-blocker-used-to-treat-heart-problems-and-other-medical-concerns-could-be-new-treatment-for-sickle-cell-cardiomyopathy/2456724/INDIANAPOLIS—A beta blocker typically used to treat heart problems, hemangioma, migraines and anxiety could be a new therapeutic for patients with sickle cell disease. Researchers led by Ankit A. De
- Novel Genetic Priority Score Unveiled to Enhance Target Prioritization in Drug Developmenthttps://reachmd.com/news/novel-genetic-priority-score-unveiled-to-enhance-target-prioritization-in-drug-development/2456726/Credit: CC0 Public Domain Driven by the need for a better way to prioritize targets for drug development, the Icahn School o
- YAP and TAZ: Protein Partners Key for Fetal Bone Developmenthttps://reachmd.com/news/yap-and-taz-protein-partners-key-for-fetal-bone-development/2456768/PHILADELPHIA— A pair of proteins, YAP and TAZ, has been identified as conductors of bone development in the womb and could provide insight into genetic diseases such as osteogenesis imperfecta, known commonly as “brittle bone disease.” This small anim
- Epilepsy Drug Could Slow Joint Damage in Osteoarthritishttps://reachmd.com/news/epilepsy-drug-could-slow-joint-damage-in-osteoarthritis/2456733/In a new study, researchers at Yale School of Medicine identify a drug that could ease the joint degeneration caused by osteoarthritis. Treatment for this common, debilitating condition has long depended on pain relievers and lifestyle changes to manage symptoms in the absence o